A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : IC/PBS / interstitial cystitis/painful bladder syndrome

[Related PubMed/MEDLINE]
Total Number of Papers: 132
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   IC/PBS  (>> Co-occurring Abbreviation)
Long Form:   interstitial cystitis/painful bladder syndrome
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2022 Upregulation of transient receptor potential cation channel subfamily M member-3 in bladder afferents is involved in chronic pain in cyclophosphamide-induced cystitis. CYP, TRPM3
2021 Hidrox and Chronic Cystitis: Biochemical Evaluation of Inflammation, Oxidative Stress, and Pain. BDNF, CYP, HO-1, Nrf2, ZO-1
2021 Is Tadalafil an Effective Treatment Option for Interstitial Cystitis/Painful Bladder Syndrome? A Report of a Challenging Case. cGMP, CPP, NO, PDE5
2021 Peripheral antinociceptive effects of a bifunctional μ and δ opioid receptor ligand in rat model of inflammatory bladder pain. BOM, IHC, OXM, UBD, VMRs
2021 Spontaneous miscarriages in patients with bladder pain syndrome/interstitial cystitis - effect of stress on inflammation? ---
2021 The relationship between illness perception and worsening of interstitial cystitis/painful bladder syndrome symptoms: A cross-sectional study. BIPQ
2020 A Comprehensive Review of the Diagnosis, Treatment, and Management of Urologic Chronic Pelvic Pain Syndrome. UCPPS
2020 Efficacy of Frankincense and Myrrha in Treatment of Acute Interstitial Cystitis/Painful Bladder Syndrome. CYP, HUCs, ZO-2
2020 Platelet-Rich Plasma Ameliorates Cyclophosphamide-Induced Acute Interstitial Cystitis/Painful Bladder Syndrome in a Rat Model. CYP, HFCs, IL-6, PRP, ZO-2
10  2020 Questionnaire-guided evaluation of the effectiveness of long-term intravesical 0.2% chondroitin sulfate therapy in interstitial cystitis. GRA, PPUFS, VAS
11  2019 Evaluation of several botulinum toxins-A delivering systems into the bladder in interstitial cystitis/painful bladder syndrome (IC/PBS). IC/BPS, ICBPS, LUTD, NDO, OAB
12  2019 Female lower urinary tract microbiota do not associate with IC/PBS symptoms: a case-controlled study. FUM
13  2019 Mechanisms Underlying Overactive Bladder and Interstitial Cystitis/Painful Bladder Syndrome. OAB
14  2019 Molecular pathogenesis of interstitial cystitis/bladder pain syndrome based on gene expression. ---
15  2019 Treatment with low-energy shock wave alleviates pain in an animal model of uroplakin 3A-induced autoimmune interstitial cystitis/painful bladder syndrome. FVC, LESW, NGF, TNF-alpha, UPK3A
16  2019 [Efficacy of electroacupuncture nerve stimulation therapy for interstitial cystitis/bladder pain syndrome]. ENST, ICPI, ICSI, VAS
17  2018 Adelmidrol + sodium hyaluronate in IC/BPS or conditions associated to chronic urothelial inflammation. A translational study. CYP
18  2018 Analysis of key genes and micro-RNA-mRNA regulatory networks in women with ulcerative interstitial cystitis/pain bladder syndrome. DEGs, GEO, IPA, PPI
19  2018 Improving the utility of clinical phenotyping in interstitial cystitis/painful bladder syndrome: from UPOINT to INPUT. CPPS, GUPI
20  2018 Morbidity rate and medical utilization in interstitial cystitis/painful bladder syndrome. ---
21  2018 Serum Cytokine Profiling in Cats with Acute Idiopathic Cystitis. FIC
22  2018 Spinal cord stimulation ameliorates detrusor over-activity and visceromotor pain responses in rats with cystitis. CYP, EUS, IBD, SCS, VMR
23  2018 The Influence of Early Life Experience on Visceral Pain. HPA, IBS
24  2018 Voluntary wheel running attenuates urinary bladder hypersensitivity and dysfunction following neonatal maternal separation in female mice. BDNF, CRF1, HPA, NMS
25  2018 Will cesarean section increase the risk of interstitial cystitis/painful bladder syndrome? CI, HR
26  2017 Bladder pain in an LL-37 interstitial cystitis and painful bladder syndrome model. MPO
27  2017 Etiology, pathophysiology and biomarkers of interstitial cystitis/painful bladder syndrome. ---
28  2017 Risk Factors of Lower Urinary Tract Syndrome among Ketamine Users. LUTS, OSPI
29  2016 Differential Expression of Renal Outer Medullary K+ Channel and Voltage-gated K+ Channel 7.1 in Bladder Urothelium of Patients With Interstitial Cystitis/Painful Bladder Syndrome. ROMK
30  2016 Impaired Na(+)/K(+)-ATPase Function in Patients with Interstitial Cystitis/Painful Bladder Syndrome. NKA
31  2016 Interstitial cystitis/painful bladder syndrome: diagnostic evaluation and therapeutic response in a private urogynecology unit. DMSO, IC, PPS
32  2016 Interstitial cystitis/painful bladder syndrome: the influence of modern diagnostic criteria on epidemiology and on Internet search activity by the public. ---
33  2016 Intravesical treatment for interstitial cystitis/painful bladder syndrome: a network meta-analysis. BCG, BoNTA, CS, GRA, PPS, RTX
34  2016 Protease-Activated Receptor 4 Induces Bladder Pain through High Mobility Group Box-1. HMGB1, MIF, PAR4, PAR4-AP, UROtsa
35  2015 A novel method for assessing bladder-related pain reveals the involvement of nerve growth factor in pain associated with cyclophosphamide-induced chronic cystitis in mice. CYP, NGF
36  2015 Advances in intravesical therapy for urinary tract disorders. ---
37  2015 Hyaluronic acid-chondroitin sulfate: a potential factor to select pure stress urinary incontinence in patients with interstitial cystitis⁄painful bladder syndrome and mixed incontinence symptoms. HA-CS, OAB
38  2015 Impaired Expression of Prostaglandin E2 (PGE2) Synthesis and Degradation Enzymes during Differentiation of Immortalized Urothelial Cells from Patients with Interstitial Cystitis/Painful Bladder Syndrome. COX-2, PGE2
39  2015 Intravesical chondroitin sulphate for interstitial cystitis/painful bladder syndrome. DMSO, GAG
40  2015 Macrophage Migration Inhibitory Factor Mediates PAR-Induced Bladder Pain. AP, MIF, PAR, UROtsa
41  2015 Unique Microstructural Changes in the Brain Associated with Urological Chronic Pelvic Pain Syndrome (UCPPS) Revealed by Diffusion Tensor MRI, Super-Resolution Track Density Imaging, and Statistical Parameter Mapping: A MAPP Network Neuroimaging Study. FA, GA, HCs, IBS, MD, TDI, UCPPS
42  2014 Chronic pelvic allodynia is mediated by CCL2 through mast cells in an experimental autoimmune cystitis model. EAC
43  2014 Chronic psychological stress in high-anxiety rats induces sustained bladder hyperalgesia. VMR, WAS, WKY
44  2014 Corticotropin-releasing factor family peptide signaling in feline bladder urothelial cells. CRF, FIC, Ucn, UT
45  2014 Decreased expression of zonula occludens-1 and occludin in the bladder urothelium of patients with interstitial cystitis/painful bladder syndrome. IF, IHC, ZO-1
46  2014 Interstitial cystitis/painful bladder syndrome: epidemiology, pathophysiology and evidence-based treatment options. ---
47  2014 Intravesical liposome and antisense treatment for detrusor overactivity and interstitial cystitis/painful bladder syndrome. ---
48  2014 Painful bladder syndrome: an update and review of current management strategies. ---
49  2014 Pretreatment features to influence effectiveness of intravesical hyaluronic Acid instillation in refractory interstitial cystitis/painful bladder syndrome. HA, ICSI, PUF, VAS
50  2014 Risk of associated conditions in relatives of subjects with interstitial cystitis. ---
51  2014 The role of cystectomy for non-malignant bladder conditions: a review. ---
52  2014 Urinary nerve growth factor could be a biomarker for interstitial cystitis/painful bladder syndrome: a meta-analysis. NGF, OAB
53  2014 Urinary nerve growth factor levels could be a biomarker for overactive bladder symptom: a meta-analysis. OAB, uNGF
54  2014 Use of vanilloids in urologic disorders. NGB, OAB, RTX
55  2014 [Risk factors for interstitial cystitis/painful bladder syndrome in patients with lower urinary tract symptoms presenting for urologic care]. LUTS
56  2013 Activation of extrinsic apoptotic pathway from bladder biopsy in patients with interstitial cystitis/painful bladder syndrome. ---
57  2013 Effect of supplementation with hydrogen-rich water in patients with interstitial cystitis/painful bladder syndrome. ---
58  2013 Repeated onabotulinumtoxin-a injections provide better results than single injection in treatment of painful bladder syndrome. BoNT-A, ICSI, VAS
59  2013 The number of existing functional somatic syndromes (FSSs) is an important risk factor for new, different FSSs. CFS, FM, FSSs, IBS
60  2013 Tryptase activation of immortalized human urothelial cell mitogen-activated protein kinase. MAP
61  2013 Uroplakin peptide-specific autoimmunity initiates interstitial cystitis/painful bladder syndrome in mice. ---
62  2012 A mouse model for interstitial cystitis/painful bladder syndrome based on APF inhibition of bladder epithelial repair: a pilot study. ANOVA, PBS, UPIII, ZO-1
63  2012 A synthetic form of frizzled 8-associated antiproliferative factor enhances p53 stability through USP2a and MDM2. APF, as-APF, MDM2, USP2a
64  2012 Does patient age impact outcomes of neuromodulation? ICSI-PI, OAB-q SF, PCS
65  2012 Increased cell apoptosis of urothelium mediated by inflammation in interstitial cystitis/painful bladder syndrome. TNF-alpha
66  2012 Intravesical onabotulinumtoxinA injections for refractory painful bladder syndrome. GRA, ICPI, ICSI, VAS
67  2012 Metabotropic glutamate receptor 5 (mGluR5) regulates bladder nociception. mGluR5, mGluRs, UPEC, VMR
68  2012 Novel Therapy with Intravesical Liposomes for Ulcerative Interstitial Cystitis/Painful Bladder Syndrome. ---
69  2012 Prognostic factors for recent-onset interstitial cystitis/painful bladder syndrome. CFS, NBSs
70  2012 [Nerve growth factor as a biomarker in the diagnosis and treatment of overactive bladder (OAB)]. OAB, OAB
71  2011 Are ulcerative and nonulcerative interstitial cystitis/painful bladder syndrome 2 distinct diseases? A study of coexisting conditions. CES-D, ICSI-PI, N-ULC, SIS, Ulc
72  2011 Evidence of bladder oversensitivity in the absence of an infection in premenopausal women with a history of recurrent urinary tract infections. UTI, UTIs
73  2011 Native antigen fractionation protein microarrays for biomarker discovery. ---
74  2011 Nerve growth factor in bladder dysfunction: contributing factor, biomarker, and therapeutic target. NGF, OAB
75  2011 Nocturia in interstitial cystitis/painful bladder syndrome. ---
76  2011 Numbers and types of nonbladder syndromes as risk factors for interstitial cystitis/painful bladder syndrome. NBSs, ORs
77  2011 Potential factors that can be used to differentiate between interstitial cystitis/painful bladder syndrome and bladder oversensitivity in women. IBS, LUTS, VAS, VUDS
78  2011 Safety and dose flexibility clinical evaluation of intravesical liposome in patients with interstitial cystitis or painful bladder syndrome. LPs
79  2011 Sexuality and reproductive risk factors for interstitial cystitis/painful bladder syndrome in women. NBSs
80  2011 State of the art in intravesical therapy for lower urinary tract symptoms. LUTS
81  2011 Symptom profile variability of interstitial cystitis/painful bladder syndrome by age. ---
82  2011 The afferent system and its role in lower urinary tract dysfunction. OABS
83  2011 [Hyperbaric oxygenation in the treatment of patients with interstitial cystitis: clinical and morphological rationale]. HBO
84  2011 [Interstitial cystitis/painful bladder syndrome: a comprehensive review of the current literature]. ---
85  2010 A multicenter, randomized, double-blind, parallel group pilot evaluation of the efficacy and safety of intravesical sodium chondroitin sulfate versus vehicle control in patients with interstitial cystitis/painful bladder syndrome. ---
86  2010 A survey of primary care physician practices in the diagnosis and management of women with interstitial cystitis/painful bladder syndrome. PCPs
87  2010 Correlations of interstitial cystitis/painful bladder syndrome with female sexual activity. ---
88  2010 Diagnosis and treatment of interstitial cystitis/painful bladder syndrome: a review. ---
89  2010 From interstitial cystitis to chronic pelvic pain. ---
90  2010 Increased nerve growth factor in neurogenic overactive bladder and interstitial cystitis patients. Cr, ELISA, NGF, NOAB, OAB, RALP
91  2010 Interstitial cystitis/painful bladder syndrome: what do patients mean by "perceived" bladder pain? ---
92  2010 Intravesical dimethyl sulfoxide inhibits acute and chronic bladder inflammation in transgenic experimental autoimmune cystitis models. DMSO
93  2010 Prevalence and impact of bacteriuria and/or urinary tract infection in interstitial cystitis/painful bladder syndrome. ---
94  2010 Psychological distress in twins with urological symptoms. GEE, PTSD
95  2010 Risk factors for interstitial cystitis/painful bladder syndrome in patients with lower urinary tract symptoms: a Chinese multi-center study. CI, LUTS, OR
96  2010 Structure-Activity Studies on Antiproliferative Factor (APF) Glycooctapeptide Derivatives. APF
97  2010 Urinary Nerve Growth Factor Levels in Urinary Tract Diseases With or Without Frequency Urgency Symptoms. ELISA, NGF, OAB
98  2010 Urinary proteomics evaluation in interstitial cystitis/painful bladder syndrome: a pilot study. A1BG, GPF, HPX, ORM1, TTR
99  2010 Urogenital complaints and female sexual dysfunction (part 1). OAB
100  2009 Breaking the cycle of pain in interstitial cystitis/painful bladder syndrome: toward standardization of early diagnosis and treatment: consensus panel recommendations. CPP